Get started
Author

Steven Joniau

Observed names: Joniau, Steven, S. Joniau
ORCID: 0000-0003-3195-9890
Observed ORCID: 0000-0003-3195-9890
OpenAlex ID: A5056556459
Final Results of the Randomised Phase 2 Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer (ARNEO)
2025 · Alexander Giesen, Gaëtan Devos, et al. · European Urology Oncology · 6
Prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: does it really have an effect on oncological outcomes?
2025 · Jonas Mennes, Murat Akand, et al. · British Journal of Urology · 2
Hematological Toxicity and Bone Marrow Dose-Volume Effects in Chemotherapy-Naïve Patients Treated With Whole Pelvic and Para-aortic Lymph Node Radiation Therapy For Pathologic Pelvic Lymph Node–Positive Prostate Cancer
2026 · Julie den Hartog, Gert De Meerleer, et al. · Advances in Radiation Oncology · 1
PDF
Addressing psychological needs in prostate cancer care: Insights from patients’ experiences and preferences
2026 · Io Wens, Alexander Giesen, et al. · PEC Global
Overall Survival After Hormones and Radiotherapy Postprostatectomy: Relevant End Point or Overrated?
2026 · Gert O. De Meerleer, Alberto Bossi, et al. · European Urology
Oligometastatic prostate cancer — bridging the gap between localized and metastatic disease
2026 · Alexander Giesen, Julie den Hartog, et al. · Nature Reviews Urology
Prognostic and Predictive Value of the Clearseq1–4 Tumor Microenvironment Classification in Localized and Metastatic Clear-Cell Renal Cell Carcinoma
2026 · Lisa Kinget, Edward Scott McTaggart, et al. · Cancer Research Communications
Interreader agreement of intraprostatic prostate cancer detection, local extension and staging using [18F]PSMA-1007 PET and whole-mount radical prostatectomy specimens
2026 · Niloefar Ahmadi Bidakhvidi, Elena Lara Jimenez, et al. · EJNMMI Research
Long-Term Outcomes and Genetic Predictors of Response to Metastasis Directed Therapy vs. Observation in Oligometastatic Castration-Sensitive Prostate Cancer: A Pooled Analysis of the STOMP and ORIOLE Trials
2022 · M.P. Deek, K. Van der Eecken, et al. · International Journal of Radiation Oncology*Biology*Physics
1381P A transcriptomic signature of AR activity prognosticates development of castration-resistance following metastasis-directed therapy in oligometastatic castration-sensitive prostate cancer
2022 · P.T. Tran, P. Sutera, et al. · Annals of Oncology
Works count: 21
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type